Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26F5ZGS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,066
Award facts
- Contract value 100% obligated
- $40,065.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $40,065.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on November 7, 2025, with completion scheduled for November 10, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026 that serves as the company's primary mechanism for supplying pharmaceuticals and medical supplies to military healthcare systems worldwide. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor specializing in brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains.
Repatha (evolocumab) is a PCSK9 inhibitor used to treat high cholesterol in patients with cardiovascular disease, and the SureClick auto-injector formulation enhances patient convenience and compliance. The delivery order fulfills Defense Health Agency pharmaceutical supply requirements through AmerisourceBergen's established role as a primary vendor for the military medical supply chain. This award reflects the company's demonstrated capability to meet federal procurement requirements and its significant role in supporting military readiness through reliable pharmaceutical distribution to military treatment facilities and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F5ZGS?
SPE2DR26F5ZGS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F5ZGS worth?
The government has obligated $40,066 on SPE2DR26F5ZGS.
Is contract SPE2DR26F5ZGS an order under another contract?
Yes. SPE2DR26F5ZGS is a delivery order under SPE2DR25D2109, an indefinite delivery contract.
Was contract SPE2DR26F5ZGS competed?
The extent of competition for SPE2DR26F5ZGS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award